PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128004
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128004
Blood Group Typing Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of blood group typing Market
The global blood group typing market was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.52 billion in 2026 to USD 5.27 billion by 2034, registering a CAGR of 9.60% during the forecast period. North America accounted for the largest market share of 34.70% in 2025, supported by the increasing demand for blood transfusions, rising adoption of automated blood typing technologies, and favorable reimbursement policies. The growing number of organ transplant procedures, expanding voluntary blood donation programs, and continuous technological advancements in transfusion diagnostics are expected to accelerate market growth throughout the forecast period.
Blood group typing is an essential diagnostic procedure that identifies an individual's blood type before blood transfusions, organ transplantation, pregnancy-related screening, and emergency trauma care. Increasing cases of chronic diseases, trauma, surgeries, and road accidents are driving demand for safe blood matching procedures worldwide. Furthermore, growing investments in automated diagnostic systems and molecular blood typing technologies are improving testing accuracy and efficiency, supporting widespread market expansion.
COVID-19 Impact
The COVID-19 pandemic temporarily slowed the blood group typing market due to reduced blood donations, fewer elective surgeries, disruptions in healthcare services, and supply chain challenges. Many diagnostic laboratories experienced lower testing volumes during lockdowns. However, the market recovered steadily in 2021 and 2022 as blood donation drives resumed, hospital admissions normalized, and healthcare providers increasingly adopted automated blood typing technologies. The restoration of blood transfusion services and growing demand for transplantation procedures continue to support market recovery.
Latest Market Trends
One of the most significant trends shaping the blood group typing market is the rapid adoption of automated blood typing technologies. Automated systems utilizing Polymerase Chain Reaction (PCR), microarray platforms, and advanced laboratory automation improve testing speed, reduce human error, and increase diagnostic accuracy.
Research institutions are also developing innovative rapid testing devices. For example, scientists from Tokyo University of Science developed a lab-on-a-chip blood typing device capable of identifying blood groups within five minutes. Such innovations are expected to improve emergency diagnostics, enhance laboratory efficiency, and strengthen market growth over the coming years.
Market Drivers
Rising Blood Donations Boost Market Growth
The increasing number of voluntary blood donations worldwide remains one of the primary growth drivers for the blood group typing market. Every blood donation requires accurate blood group determination, antibody screening, and compatibility testing before transfusion.
Growing awareness campaigns by healthcare organizations and governments encouraging voluntary blood donations are significantly increasing testing volumes. Additionally, rising demand for blood components in surgeries, cancer treatment, trauma care, and chronic disease management continues to expand the need for blood typing procedures globally.
Increasing Organ Transplantation Procedures Fuel Demand
The growing number of kidney, liver, heart, and bone marrow transplant procedures is significantly increasing demand for Human Leukocyte Antigen (HLA) typing and cross-matching tests. Accurate blood group typing minimizes transplant rejection and improves patient outcomes.
Continuous improvements in transplant infrastructure, increasing donor registrations, and rising investments in transplant medicine are expected to further stimulate market growth throughout the forecast period.
Market Restraints
Despite strong growth prospects, limited healthcare infrastructure and shortages of skilled laboratory professionals continue to restrict market expansion in several developing countries. Many emerging nations face inadequate blood banking facilities, insufficient laboratory equipment, unreliable electricity supply, and limited reimbursement policies, reducing access to advanced blood group typing technologies.
Additionally, high equipment costs and funding limitations continue to challenge widespread adoption of automated testing platforms in low-resource healthcare systems.
Market Segmentation
Based on product, the market is segmented into instruments and reagents & kits. The reagents & kits segment is expected to dominate the market with a 80.43% share in 2026, owing to increasing blood donations, transfusion procedures, and recurring demand for testing consumables. The instruments segment is projected to witness steady growth with increasing adoption of automated laboratory systems.
Based on test type, the market includes ABO tests, antigen typing, antibody screening, cross-matching tests, and HLA typing. The antibody screening segment is expected to hold the largest 39.80% market share in 2026, driven by rising prenatal screening, transfusion safety requirements, and increasing transplantation procedures.
Based on technique, the market is divided into serology and molecular tests. The serology segment is projected to account for 59.42% of the market in 2026, supported by its widespread availability, affordability, and routine use in blood banks. Molecular testing is anticipated to witness faster growth due to higher accuracy and expanding applications in complex blood typing.
Based on end user, the market is categorized into hospital-based laboratories and independent laboratories & blood banks. The independent laboratories & blood banks segment is expected to dominate with a 59.42% share in 2026, supported by expanding laboratory networks and increasing blood donation activities worldwide.
Regional Insights
North America remained the largest regional market with a valuation of USD 0.80 billion in 2025 and is projected to reach USD 0.86 billion in 2026. Strong healthcare infrastructure, high blood transfusion volumes, widespread adoption of automated diagnostic systems, and favorable reimbursement policies continue to strengthen regional market growth.
Europe accounted for USD 0.65 billion in 2025 and is expected to reach USD 0.71 billion in 2026. Rising awareness regarding blood donation, expanding organ transplantation programs, and government initiatives supporting healthcare modernization are driving regional demand.
Asia Pacific generated USD 0.65 billion in 2025 and is projected to reach USD 0.73 billion in 2026. Rapid healthcare infrastructure development, increasing research activities, technological innovations, and expanding blood donation campaigns across China, Japan, and India are fueling market growth.
Latin America reached USD 0.11 billion in 2025 and is expected to grow to USD 0.12 billion in 2026, while the Middle East & Africa market increased from USD 0.09 billion in 2025 to USD 0.10 billion in 2026, supported by improving blood banking infrastructure and increasing awareness regarding safe blood transfusion practices.
Competitive Landscape
The global blood group typing market is moderately consolidated, with leading companies focusing on product innovation, automation, strategic collaborations, acquisitions, and geographic expansion. Continuous investments in molecular diagnostics, automated analyzers, and next-generation HLA typing technologies are strengthening competitive positioning.
Major companies operating in the market include Quotient Limited, CareDx Inc., Agena Bioscience, DIAGAST, Illumina, Grifols S.A., Immucor, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN, Beckman Coulter Inc., and QuidelOrtho Corporation.
Recent industry developments include Quotient's expansion of ALBA products across Europe and Southeast Asia, Bio-Rad Laboratories' launch of the IH-500 NEXT automated system, Metropolis Healthcare's NextGen HLA Typing Test introduction, Werfen's acquisition of Immucor, and continued commercialization of next-generation molecular blood typing technologies.
Conclusion
The global blood group typing market is expected to witness robust growth over the forecast period, driven by increasing blood donations, rising organ transplantation procedures, expanding trauma care requirements, and growing adoption of automated diagnostic technologies. Continued technological advancements, supportive government initiatives promoting voluntary blood donation, and expanding healthcare infrastructure across emerging economies are expected to create significant growth opportunities. As healthcare providers increasingly prioritize transfusion safety, rapid diagnostics, and precision medicine, blood group typing technologies will remain an indispensable component of modern clinical diagnostics and transfusion medicine.
Segmentation By Product
- Instruments
- Reagents & Kits
By Test Type
- ABO Tests
- Antigen Typing
- Antibody Screening
- Cross-matching Tests
- HLA Typing
By Technique
- Serology Tests
- Molecular Tests
By End-user
- Hospital-based Laboratories
- Independent Laboratories & Blood Banks
By Region
- North America (By Product, By Test Type, By Technique, By End-user, and By Country)
- U.S.
- Canada
- Europe (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Technological Advancements in Blood Group Typing Techniques
- 4.2. Number of Blood Donations, For Key Countries
- 4.3. Number of Blood Transfusions, For Key Countries/ Region
- 4.4. Key Industry Developments: Mergers, Partnership, Acquisitions
- 4.5. Brief Overview of Other Companies Operating in HLA Typing Products
- 4.6. Pricing Analysis of HLA Typing Products
- 4.7. Impact of COVID-19 on Blood Group Typing Market
5. Global Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Instruments
- 5.1.2. Reagents & Kits
- 5.2. Market Analysis, Insights and Forecast - By Test Type
- 5.2.1. ABO Tests
- 5.2.2. Antigen Typing
- 5.2.3. Antibody Screening
- 5.2.4. Cross-matching Tests
- 5.2.5. HLA Typing
- 5.3. Market Analysis, Insights and Forecast - By Techniques
- 5.3.1. Serology Tests
- 5.3.2. Molecular Tests
- 5.4. Market Analysis, Insights and Forecast - By End-user
- 5.4.1. Hospital-based Laboratories
- 5.4.2. Independent Laboratories & Blood Banks
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Instruments
- 6.1.2. Reagents & Kits
- 6.2. Market Analysis, Insights and Forecast - By Test Type
- 6.2.1. ABO Tests
- 6.2.2. Antigen Typing
- 6.2.3. Antibody Screening
- 6.2.4. Cross-matching Tests
- 6.2.5. HLA Typing
- 6.3. Market Analysis, Insights and Forecast - By Techniques
- 6.3.1. Serology Tests
- 6.3.2. Molecular Tests
- 6.4. Market Analysis, Insights and Forecast - By End-user
- 6.4.1. Hospital-based Laboratories
- 6.4.2. Independent Laboratories & Blood Banks
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Instruments
- 7.1.2. Reagents & Kits
- 7.2. Market Analysis, Insights and Forecast - By Test Type
- 7.2.1. ABO Tests
- 7.2.2. Antigen Typing
- 7.2.3. Antibody Screening
- 7.2.4. Cross-matching Tests
- 7.2.5. HLA Typing
- 7.3. Market Analysis, Insights and Forecast - By Techniques
- 7.3.1. Serology Tests
- 7.3.2. Molecular Tests
- 7.4. Market Analysis, Insights and Forecast - By End-user
- 7.4.1. Hospital-based Laboratories
- 7.4.2. Independent Laboratories & Blood Banks
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Instruments
- 8.1.2. Reagents & Kits
- 8.2. Market Analysis, Insights and Forecast - By Test Type
- 8.2.1. ABO Tests
- 8.2.2. Antigen Typing
- 8.2.3. Antibody Screening
- 8.2.4. Cross-matching Tests
- 8.2.5. HLA Typing
- 8.3. Market Analysis, Insights and Forecast - By Techniques
- 8.3.1. Serology Tests
- 8.3.2. Molecular Tests
- 8.4. Market Analysis, Insights and Forecast - By End-user
- 8.4.1. Hospital-based Laboratories
- 8.4.2. Independent Laboratories & Blood Banks
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Instruments
- 9.1.2. Reagents & Kits
- 9.2. Market Analysis, Insights and Forecast - By Test Type
- 9.2.1. ABO Tests
- 9.2.2. Antigen Typing
- 9.2.3. Antibody Screening
- 9.2.4. Cross-matching Tests
- 9.2.5. HLA Typing
- 9.3. Market Analysis, Insights and Forecast - By Techniques
- 9.3.1. Serology Tests
- 9.3.2. Molecular Tests
- 9.4. Market Analysis, Insights and Forecast - By End-user
- 9.4.1. Hospital-based Laboratories
- 9.4.2. Independent Laboratories & Blood Banks
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Instruments
- 10.1.2. Reagents & Kits
- 10.2. Market Analysis, Insights and Forecast - By Test Type
- 10.2.1. ABO Tests
- 10.2.2. Antigen Typing
- 10.2.3. Antibody Screening
- 10.2.4. Cross-matching Tests
- 10.2.5. HLA Typing
- 10.3. Market Analysis, Insights and Forecast - By Techniques
- 10.3.1. Serology Tests
- 10.3.2. Molecular Tests
- 10.4. Market Analysis, Insights and Forecast - By End-user
- 10.4.1. Hospital-based Laboratories
- 10.4.2. Independent Laboratories & Blood Banks
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Quotient Limited
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. CareDx Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Agena Bioscience, Inc. (Mesa Laboratories, Inc.)
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. DIAGAST
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Illumina, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Grifols, S.A.
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Immucor, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Bio-Rad Laboratories, Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Thermo Fisher Scientific Inc.
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Merck KGaA
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. QIAGEN
- 11.2.11.1. Overview
- 11.2.11.2. Products & Services
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
- 11.2.12. Beckman Coulter, Inc. (Danaher)
- 11.2.12.1. Overview
- 11.2.12.2. Products & Services
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Strategies
- 11.2.12.6. Financials (Based on Availability)
- 11.2.13. QuidelOrtho Corporation
- 11.2.13.1. Overview
- 11.2.13.2. Products & Services
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Strategies
- 11.2.13.6. Financials (Based on Availability)
- 11.2.1. Quotient Limited
List of Tables
- Table 01: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 02: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
- Table 03: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
- Table 04: Global Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 05: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Region, 2021-2034
- Table 06: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 07: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
- Table 08: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
- Table 09: North America Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 10: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 11: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 12: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
- Table 13: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
- Table 14: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 15: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 16: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 17: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
- Table 18: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
- Table 19: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 20: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 21: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 22: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
- Table 23: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
- Table 24: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 25: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 26: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
- Table 27: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
- Table 28: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
- Table 29: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
- Table 30: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
List of Figures
- Figure 01: Global Blood Group Typing Market Value Share (%), By Product, 2025 & 2034
- Figure 02: Global Blood Group Typing Market Value Share (%), By Test Type, 2025 & 2034
- Figure 03: Global Blood Group Typing Market Value Share (%), By Techniques, 2025 & 2034
- Figure 04: Global Blood Group Typing Market Value Share (%), By End User, 2025 & 2034
- Figure 05: Global Blood Group Typing Market Value Share (%), By Region, 2025 & 2034
- Figure 06: North America Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
- Figure 07: North America Blood Group Typing Market Value Share (%), By Product, 2025
- Figure 08: North America Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
- Figure 09: North America Blood Group Typing Market Value Share (%), By Test Type, 2025
- Figure 10: North America Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
- Figure 11: North America Blood Group Typing Market Value Share (%), By Techniques, 2025
- Figure 12: North America Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
- Figure 13: North America Blood Group Typing Market Value Share (%), By End User, 2025
- Figure 14: North America Blood Group Typing Market Value (USD billion), By Country, 2025 & 2034
- Figure 15: North America Blood Group Typing Market Value Share (%), By Country, 2025
- Figure 16: Europe Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
- Figure 17: Europe Blood Group Typing Market Value Share (%), By Product, 2025
- Figure 18: Europe Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
- Figure 19: Europe Blood Group Typing Market Value Share (%), By Test Type, 2025
- Figure 20: Europe Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
- Figure 21: Europe Blood Group Typing Market Value Share (%), By Techniques, 2025
- Figure 22: Europe Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
- Figure 23: Europe Blood Group Typing Market Value Share (%), By End User, 2025
- Figure 24: Europe Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
- Figure 25: Europe Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
- Figure 26: Asia Pacific Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
- Figure 27: Asia Pacific Blood Group Typing Market Value Share (%), By Product, 2025
- Figure 28: Asia Pacific Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
- Figure 29: Asia Pacific Blood Group Typing Market Value Share (%), By Test Type, 2025
- Figure 30: Asia Pacific Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
- Figure 31: Asia Pacific Blood Group Typing Market Value Share (%), By Techniques, 2025
- Figure 32: Asia Pacific Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
- Figure 33: Asia Pacific Blood Group Typing Market Value Share (%), By End User, 2025
- Figure 34: Asia Pacific Blood Group Typing Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
- Figure 35: Asia Pacific Blood Group Typing Market Value Share (%), By Country/ Sub-Region, 2025
- Figure 36: Latin America Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
- Figure 37: Latin America Blood Group Typing Market Value Share (%), By Product, 2025
- Figure 38: Latin America Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
- Figure 39: Latin America Blood Group Typing Market Value Share (%), By Test Type, 2025
- Figure 40: Latin America Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
- Figure 41: Latin America Blood Group Typing Market Value Share (%), By Techniques, 2025
- Figure 42: Latin America Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
- Figure 43: Latin America Blood Group Typing Market Value Share (%), By End User, 2025
- Figure 44: Latin America Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
- Figure 45: Latin America Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
- Figure 46: Middle East & Africa Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
- Figure 47: Middle East & Africa Blood Group Typing Market Value Share (%), By Product, 2025
- Figure 48: Middle East & Africa Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
- Figure 49: Middle East & Africa Blood Group Typing Market Value Share (%), By Test Type, 2025
- Figure 50: Middle East & Africa Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
- Figure 51: Middle East & Africa Blood Group Typing Market Value Share (%), By Techniques, 2025
- Figure 52: Middle East & Africa Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
- Figure 53: Middle East & Africa Blood Group Typing Market Value Share (%), By End User, 2025
- Figure 54: Middle East & Africa Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
- Figure 55: Middle East & Africa Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
- Figure 56: Global Blood Group Typing Market Share (%), By Company, 2025
